Recent research has unveiled promising potential in treating anxiety disorders with cannabis-based medical formulations (CBMFs), specifically enriched cannabidiol (CBD) oil extracts. Conducted during the COVID-19 pandemic at the Zerenia Clinic in BogotΓ‘, Colombia, this study highlights the effectiveness and tolerability of these formulations in alleviating anxiety symptoms in adults. Below, we delve into the key findings and implications of this groundbreaking discovery.
A cohort of 24 adults participated in this observational, retrospective case series, utilizing electronic health records from June 2021 to December 2022. Each participant was prescribed non-sterile oral liquids with enriched CBD, targeting unspecified anxiety disorder as per DSM-5 criteria.
The study assessed the anxiety subscale on the Hospital Anxiety and Depression Scale (HADS-A) and the clinical global impression scale with regard to severity (CGI-S) and improvement (CGI-I) at the start, middle, and end of the 12-month follow-up.
Secondary outcomes indicated improvements in sleep disturbances. Initially, less than half (46.83%) reported significant daytime sleepiness, which reduced to less than a third (29.17%) post-treatment over 6 months. Remarkably, 87.50% achieved normal daytime sleepiness by the studyβs conclusion.
No clinically relevant depressive symptoms were observed at baseline in HADS-D scores, thus showing no progression over time. Minimal gender differences were noted, potentially due to menopause-related symptoms.
While the study confirmed the potential effectiveness and safety of enriched CBD oil extracts, further research is essential to ascertain long-term efficacy and the optimal dosages for treating specific anxiety disorders (ADs). Future research should also consider head-to-head trials comparing CBMFs with current first-line treatments for ADs.
The promising results warrant the undertaking of randomized controlled trials to establish definitive conclusions on CBMFs as viable treatment options for anxiety disorders.
The pioneering study from Zerenia Clinic brings hope in the realm of anxiety treatments, placing enriched CBD oil extracts at the forefront. With its potential to significantly reduce anxiety symptoms and improve sleep quality without adverse effects, this discovery may redefine therapeutic approaches in anxiety disorders. However, continued research is critical to solidifying CBDβs role in mental health pharmacotherapy.
For more details, visit the source.
Exploring the Role of Cannabinoids in Peripheral Neuropathy Management Peripheral neuropathy, a condition that wreaks…
Unlocking Nature's Code: What 6 Phytochemicals Can Teach Us About Autism? Autism Spectrum Disorder (ASD)…
Unlocking Life's Potential: How CBD May Help You Live Longer, Healthier πΏπ‘ As the global…
πΏ Discovering CBD: The Secret to Recovering from Sports Injuries? ποΈββοΈ In recent years, Cannabidiol,…
Halting Parkinson's Progression: A Breakthrough with Immune System Tweaks Imagine being able to stop the…
Unlocking Migraine Relief: Could Cannabinoid Therapies Hold the Key? Migraine sufferers know all too well…